La gestione del paziente diabetico tra presente e futuro
DOI:
https://doi.org/10.19156/abtpn.2017.0021Keywords:
Type 2 diabetes, Cardiovascular risk, Empagliflozin, End-stage renal diseaseAbstract
No abstract available (Diabetology)
No abstract available (Diabetology)
You may also start an advanced similarity search for this article.
Copyright (c) 2017 The authors

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.